Xtalks — The Life Science Community™, Online webinar
2026-11-18
Successful biologics programs depend on making the right decisions at the right stage of development. Early choices in cell culture strategy, media and feed optimization, downstream recovery, analytical control strategy and scale-up approach can significantly affect yield, quality profile and manufacturing consistency later in the life cycle. In a competitive environment, development teams must balance speed, risk and platform fit while preserving flexibility for future process evolution. This webinar will explore practical decision points across the biologics product life cycle, with emphasis on how process development, manufacturing science and quality systems can work as one integrated system. The featured speaker will examine how data packages, design space knowledge and risk-based planning support smoother technology transfer, reduce development risk and costly rework, improve process performance and enable faster GMP execution. By connecting development decisions with downstream manufacturing requirements, the session will demonstrate how an integrated development-to-manufacturing approach can support reliable, reproducible and commercially relevant supply. Register for this webinar to learn how product life cycle decisions can improve biologics process performance, technology transfer and GMP execution.
|
|